Abstract:Objective: To investigate the role of dexmedetomidine (DEX) in the inhibition of diabetic peripheral neuropathy (DPN) and the protection in the nerve damage.Methods: Eighty male Sprague-Dawley (SD) rats were randomly allocated to four groups: the control group (C group), DPN model group (DPN group), DEX-treated group (DEX group), and the yohimbine treated group (YOH group). DPN was induced by intraperitoneal administration of streptozocin (STZ) (35 mg/kg). The body weights, blood glucose level, mechanical withdrawal threshold (MWT), thermal withdrawal latency (TWL), the motor, and sensory nerve conduction velocities (MNCV and SNCV) of sciatic nerve were measured. Then the sciatic nerve was isolated for H&E staining and immunohistochemical staining. The oxidative stress makers such as malondialdehyde (MDA), superoxide-dismutase (SOD), and glutathione peroxidase (GSH-Px) and apoptosis related cytokines such as Bax, Bcl-2, and caspase-3 were estimated.Results: There was no significant difference of the blood glucose and body weight among the DPN group, DEX group, and YOH group. H&E staining showed that DEX treatment can ameliorate the damage of sciatic nerve cells. In the DPN group, MWT, TWL, MNCV, and SNCV were significantly reduced compared with the C group (P < 0.05). In DEX group rats, MWT, TWL, MNCV, and SNCV were increased significantly (P < 0.05) compared with the DPN group and YOH group rats. Lower SOD and GSH-Px, and higher MDA were found in the DPN group compared with the C group (P < 0.01), and DEX treatment restored SOD, GSH-px, and MDA activity significantly (P < 0.01). The expression levels of Bax and caspase-3 were increased, while that of Bcl-2 was decreased significantly in the DPN group compared with the C group (P < 0.05). In the DEX group, the expression levels of Bax and caspase-3 were decreased significantly (P < 0.05), while that of Bcl-2 was increased significantly (P < 0.05) compared with the DPN group and the YOH group.Conclusion: The results of this study demonstrated that DEX has the inhibitory and protective effects on DPN of rats. This may be associated with its antioxidative and anti-apoptosis responses.

Molecular Mechanism of Dexamethasone Affecting Podocyte Motility

Α‐actinin‐4 is Involved in the Process by Which Dexamethasone Protects Actin Cytoskeleton Stabilization from Adriamycin‐induced Podocyte Injury

Dexmedetomidine Suppresses Oxidative Stress and Inflammation of Nucleus Pulposus Cells by Activating the PI3K/Akt Signaling Pathway.

Dexamethasone Inhibits Podocyte Apoptosis by Stabilizing the PI3K/Akt Signal Pathway

Dexmedetomidine alleviates high glucose-induced podocyte damage by inhibiting EDA2R

Mechanism of Dexamethasone Inhibiting U937 Cell Adhesion and Phagocytose Function

The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.

Alteration of Podocyte Protein Expression and Localization in the Early Stage of Various Hemodynamic Conditions

Effects of Dexamethasone and Latrunculin A on Expression of Protein in Human Trabecular Meshwork Cell

Effects of Dexamethasone on Angiotensin II-induced Changes of Monolayer Permeability and F-actin Distribution in Glomerular Endothelial Cells

Protective Effect of Dexamethasone on the Kidneys of Rats with Severe Acute Pancreatitis and its Mechanism.

Dexamethasone Prevents Monocyte‐induced Tubular Epithelial–mesenchymal Transition in HK‐2 Cells

Effects of Dexamethasone on Alveolar Fluid Clearance in Mouse Asthma Models

The Protective Effect and Mechanism of Dexmedetomidine on Diabetic Peripheral Neuropathy in Rats

Effect of the Knockdown of Podocin mRNA on Nephrin and α-Actinin in Mouse Podocyte

The Effect of Dexamethasone on Expression of Aquaporin- 1 in Cultured Human Trabecular Meshwork Cells

Diversities of podocyte molecular changes induced by different antiproteinuria drugs.

Involvement of Mapk Phosphatase-1 in Dexamethasone-Induced Chemoresistance in Lung Cancer

Inhibitory Effects of Pharmacological Doses of Dexamethasone on Mineralization of Mesenchymal Progenitor Cells in Vitro.

[Inhibitory Effect of Dexamethasone on Myeloid Differentiation Factor 88 and Tumor Necrosis Factor-Alpha Expressions in Mouse Peritoneal Macrophages].

Effect of activating PKA signaling on dedifferentiation of podocytes in adriamycin-induced nephropathy mice